🇺🇸 FDA
Patent

US 11666594

Antibody-drug conjugates comprising a cyclic dinucleotide

granted A61KA61K31/7076A61K31/7084

Quick answer

US patent 11666594 (Antibody-drug conjugates comprising a cyclic dinucleotide) held by Takeda Pharmaceutical Company Limited expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/7076, A61K31/7084, A61K47/6807, A61K47/6871